🟢 Cue Biopharma is trading 12.1% up today after announcing a $50M private placement

Cue Biopharma is trading 12.1% up at $40.92 after announcing a $50 million private placement priced at $33.21 per share with accredited investors.

• The financing deal is expected to close around July 13, 2026, and is intended to strengthen the company’s cash position.
• Proceeds from the placement will be used to advance the development of the company’s immunotherapy pipeline.